Top Stories
-
A new study shows how modifications to the tau protein may influence the different ways it can misfold in the brain, which is closely linked to the type of neurodegenerative disease that develops.
Topic
-
This July, Columbia neurologist Mitch Elkind will become president of the American Heart Association, only the second time a neurologist has led the organization.
Topic
-
Patients taking the recommended diuretic for hypertension experienced more potentially serious side effects than those taking a similar drug, according to a new study from Columbia researchers.
Topic
-
The source of essential tremor—involuntary, rhythmic trembling—has been elusive, but a new study points to abnormal electrical activity in the base of the brain.
Topic
Latest News
- January 24, 2018
Clinical trial shows that solanezumab, an antibody-based treatment for Alzheimer’s disease, does not significantly slow cognitive decline.
Topic
- January 16, 2018
Columbia neurologists and engineers are using a robotic device to investigate how Parkinson’s affects the ability to walk and respond to balance perturbations.
Topic
- December 29, 2017
A community wellness center led by two P&S faculty members will strengthen initiatives in stroke prevention and mental health support.
Topic
- December 1, 2017
A new study finds that periodically reanalyzing epilepsy patients' DNA may aid in diagnosis and treatment.
Topic
- November 22, 2017
New video that reveals how immune cells breach the blood-brain barrier is giving scientists new ideas about treating multiple sclerosis.
Topic
- November 17, 2017
Researchers at Columbia University found that dementia is on the decline in seniors from northern Manhattan, following national trends.
Topic
- November 13, 2017
A new study suggests a smell test can identify people with mild cognitive impairment–often a precursor to Alzheimer’s–who may benefit from cholinesterase inhibitors.
Topic
- November 8, 2017
New Zika research from Columbia University suggests that high rates of microcephaly in Brazil were not caused by new mutations in the virus, as previously believed.
Topic
- October 3, 2017
Scientists propose a new model for Alzheimer's disease that may explain the high failure rate of recent clinical trials.
Topic
- September 18, 2017
A cellular defense against protein aggregates suppresses ALS in early stages but later hastens spread of the disease, a study in mice suggests.
Topic
